Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02750449 · ClinicalTrials.gov registry record · NA
Human Photoallergy Test
A NA study of Sunscreening Agents, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT02750449: Completed NA study of Sunscreening Agents, sponsored by Bayer.
NCT02750449 is a NA study of Sunscreening Agents that has completed, run by Bayer. The registered enrollment target is 54 participants, below the 79-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02750449, a NA study of Sunscreening Agents, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the potential of a test material to produce a photo allergic response.
Conditions Studied
Interventions
- DRUG Sun screening Sport Lotion, (BAY987516)
- OTHER Untreated skin
Study Locations (1)
New Jersey
- - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2016-05-09 |
| Est. Completion | 2016-07-01 |
| Phase | NA |
What the finished NCT02750449 record still lists
NCT02750449 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 79-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (32% lower).
The record links to 1 condition, with Sunscreening Agents appearing as the primary indexed condition, and to 2 interventions - of which Sun screening Sport Lotion, (BAY987516) is the first listed.
NCT02750449 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT02750449 about?
NCT02750449 is a clinical study titled "Human Photoallergy Test". To evaluate the potential of a test material to produce a photo allergic response.
What is the current status of trial NCT02750449?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2016-05-09. Estimated completion is 2016-07-01.
What conditions does trial NCT02750449 study?
This clinical trial studies the following conditions: Sunscreening Agents.
What interventions are being tested in trial NCT02750449?
The interventions under investigation include: Sun screening Sport Lotion, (BAY987516) (DRUG), Untreated skin (OTHER).
Who is sponsoring clinical trial NCT02750449?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02750449 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sunscreening Agents
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02750449's enrollment target sits among peer trials
54 4th of 21 higher than 17 of 21 other Sunscreening Agents trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sunscreening Agents trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Sunscreen Dispensers in Parks Visited by Teenagers
ACTIVE NOT RECRUITING · NA
-
Clinical Study to Evaluate the Sun Protection Factor (SPF) of Three Sunscreen Products
COMPLETED · NA
-
To Assess the Safety of a Sunscreen Product
COMPLETED · NA
-
Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating (821/2016)
COMPLETED · NA
-
Sun Protection Factor Assay (SPF Assay 204/2016)
COMPLETED · NA
-
18794 - Human Photo Toxicity Test
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI